Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children

International Journal of Cancer

Volumn 69, Issue 2, 1996, Pages 146-151

  Vassal, Gilles ^a   Terrier Lacombe, Marie José ^a   Lellouch Tubiana, Arielle ^b   Valery, Charles A ^a   Sainte Rose, Christian ^b   Morizet, Jackie ^a   Ardouin, Patrice ^a   Riou, Guy ^a   Kalifa, Chantai ^a   Gouyette, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; TUMOR XENOGRAFT;

ANIMALS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; MALE; MEDULLOBLASTOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROECTODERMAL TUMORS, PRIMITIVE; PROGNOSIS; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 15844397395     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<146::AID-IJC14>3.0.CO;2-7     Document Type: Article

References (26)

1. ADESINA, A.M., NALBANTOGLU, J. and CAVENEE, W.K., p53-gene mutation and mdm2-gene amplification are uncommon in medulloblastoma. Cancer Res., 54, 5649-5651 (1994).
2. BATRA, K., MCLENDON, R.E., KOO, J.S., CASTELINO-PRABHU, S., FUCHS, H.E., KRISCHER, J.P., FRIEDMAN, H.S., BIGNER, D.D. and BIGNER, S.H., Prognostic implications of chromosome-17p deletions in human medulloblastomas. J. Neuro-oncol., 24, 39-45 (1995).
3. BETTAN-RENAUD, L., BAYLE, C, TEYSSIER, J.R. and BÉNARD, J., Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line IGR-N-835. Int. J. Cancer. 44, 460-466 (1989).
4. BIGNER, S.H., FRIEDMAN, H.S., VOGELSTEIN, B., OAKES, W.J. and BIGNER, D.D., Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res., 50, 2347-2350 (1990).
5. BIGNER, S.H. and VOGELSTEIN, B., Cytogenetics and molecular genetics of malignant gliomas and medulloblastomas. Brain Pathol., 1, 12-18 (1990).
6. COFFIN, C.M., MUKAI, K. and DEHNER, L.P., Glial differentiation in medulloblastomas: histogenetic insight, glial reaction or invasion of brain? Amer. J. surg. Pathol., 7, 555-565 (1983).
7. DUINKERKE, S.J., SLOOFF, J.L., GABREELS, F.J.M., RENIER, W.O., THUSSEN, H.O.M. and BIESTA, J.H., Melanotic rhabdomyomedulloblastoma or teratoid tumor of the cerebellar vermis Clin. Neurol. Neurosurg., 93, 29-32 (1981).
8. FODSTAD, O., Representativity of xenografts for clinical cancer: tumor and host characteristics as variables of tumor take rate. In: B. Winograd, M.J. Peckhman and H.M. Pinedo (eds.), Human rumour xenografts in anti-cancer-drug development, pp. 15-21, Springer, Berlin (1988).
9. FRIEDMAN, H.S., OAKES, W.J., BIGNER, S.H., WIKSTRAND, C.J. and BIGNER, D.D., Medulloblastoma: tumor biological and clinical perspectives. J. Neuro-oncol., 11, 1-15 (1991).
10. 2/neu proto-oncogenes in human breast carcinomas: correlation with prognosis. Oncogens Res., 3, 21-31 (1988).
11. HARISIADIS, L. and CHANG, C.H., Medulloblastoma in children: a correlation between staging and results of treatment. Int. J. Radiat. Oncol. Biol. Phys., 2, 833-837 (1977).
12. HEIDEMAN, R.L., PACKER, R.J., ALBRIGHT, L.A., FREEMAN, C.R. and RORKE, L.B., Tumors of the central nervous system. In: P.A. Pizzo and D.G. Poplack (ads.). Principles and practice of pediatric oncology, 2nd ed., pp. 633-681, J.B. Lipincott, Philadelphia (1993).
13. KALIFA, C., RAQUIN, M., BOUFFET, E., GENTET, J.C., DOZ, F., CHASTAGNER, P., PEREL, Y. and MACDOWELL, H., Chemotherapy without irradiation in medulloblastoma patients younger than 3: a prospective study by the French Society of Pediatric Oncology (SFOP). Proc. Amer. Soc. clin. Oncol., 14, 438 (1995).
14. LE DOUARIN, N.M., Cell-lineage segregation during neuraf-crest ontogeny. Ann. N.Y. Acad. Sci., 599, 131-140 (1990).
15. LITTLE, C.D. and MINNA, J.D., Amplification and expression of the c-myc oncogene in human lung-cancer cell lines. Nature (Lond.), 306, 194-196 (1983).
16. MATTERN, J., BAK, M., HAHN, E.W. and VOLM, M., Human tumor xenografts as model for drug testing. Cancer Metastasis Rev., 7, 263-284 (1988).
17. MODJTAHEDI, N., LAVIALLE, C., POUPON, M.F., LANDIN, R.M., CASSINGENA, R., MONIER, R. and BRISON, O., Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast-carcinoma cell line. Cancer Res., 45, 4372-4379 (1985).
18. NEELY, J.E., BALLARD, E.T., BRITT, A.L. and WORKMAN, L., Characteristics of 85 pediatric tumor heterotransplanted into nude mice. Exp. Cell Biol., 51, 217-227 (1983).
19. PIETSCH, T., SCHARMANN, T., FONATSCH, C., SCHMIDT, D., ÖCKLER, R., FREIHOFF, D., ALBRECHT, S., WIESTLER, O.D., ZELTZER, P. and RIEHM, H., Characterization of five new cell lines derived from human primitive neuro-ectodermal tumors of the central nervous system. Cancer Res., 54, 3278-3287 (1994).
20. RORKE, L.B., GILLES, F.H., DAIS, R.L. and BECKER, L.E., Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer, 56, 1869-1886 (1985).
21. ROUAH, E., WILSON, D.R., ARMSTRONG, D.L. and DARLINGTON, G.L., N-myc amplification and neuronal differentiation in human primitive neuro-ectodermal tumors of the central nervous system. Cancer Res., 49, 1797-1801 (1989).
22. RUSSELL, D.S. and RUBINSTEIN, L.J., Embryonal tumours with potential bimodal lines of differentiation. In: D.S. Russell and L.J. Rubinstein (eds.), Pathology of tumours of the nervous system, 5th ed., pp. 687-688, Arnold, London (1989).
23. SCHWAB, M., ELLISON, J., BUSCH, M., ROSENAU, W., VARMUS, H.E. and BISHOP, J.M., Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc. nat. Acad. Sci (Wash.), 81, 4940-4944 (1984).
24. VASSAL, G., MORIZET, J., BISSERY, M.C., BOLAND, I., ARDOUIN, P., MATHIEU-BOUÉ, A. and GOUYETTE, A., Activity of the camptothecin analog CPT-11 (Irinotecan) against medulloblastoma xenografts. Proc. Amer. Ass. Cancer Res., 35, 366 (1994).
25. WEEKS, D.A., MALOTI, R.L., ZUPPAN, C.W., LIWNICZ, B.H. and BECKWITH, J.B., Primitive cerebral tumor with rhabdoid features: a case of phenotypic rhabdoid tumor of the central nervous system. Ultrastructural Pathol, 18, 23-28 (1994).
26. WINOGRAD, B., LOBBEZZOO, M.W. and PINEDO, H.M., Proposal for the application of xenografts in screening for new anti-cancer agents and in selecting tumor types for phase-II clinical trials. In: B. Winograd, M.J. Peckhman and H.M. Pinedo (eds.), Human tumour xenografts in anti-cancer drug development, pp. 111-114, Springer, Berlin (1988).